Schrödinger Stock (NASDAQ:SDGR)
Previous Close
$12.16
52W Range
$11.11 - $27.63
50D Avg
$14.50
200D Avg
$18.60
Market Cap
$923.55M
Avg Vol (3M)
$1.33M
Beta
1.65
Div Yield
-
SDGR Company Profile
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
SDGR Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 22 |
|---|---|---|---|
| Software Products And Services | $199.50M | $180.37M | - |
| Professional Services | $9.65M | $9.80M | - |
| Revenue From Contract With Customer Before Software Contribution | $183.51M | $172.35M | - |
| On Premise Software | $101.45M | $104.02M | - |
| Hosted Software | $45.12M | $35.25M | - |
| Maintenance | $27.29M | $23.28M | - |
| Software Contribution | $15.99M | $8.02M | - |
| Drug Discovery Contribution | - | - | $1.95M |
Fiscal year ends in Dec 25 | Currency in USD